National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
March 20, 2012 • Volume 9 / Number 6

Notes

NCI and CICAMS Sign Statement of Intent

Drs. Jie He and Harold Varmus sign a Statement of Intent Drs. Jie He and Harold Varmus during a recent signing ceremony on March 14

Dr. Jie He, president of the Cancer Institute and Hospital of the Chinese Academy of Medical Sciences (CICAMS), and NCI Director Dr. Harold Varmus signed a statement of intent to share an interest in fostering collaborative biomedical research in oncology and a common goal in educating and training the next generation of cancer research scientists and clinicians. The signing took place March 14 during the Setting Priorities for Global Cancer Research meeting, hosted by NCI's Center for Global Health.
 
NCI and CICAMS aim to improve the discovery and development of new anticancer agents and prevention strategies to enhance the design, implementation, and analysis of cancer treatment and prevention trials, basic science research, and epidemiologic studies.

NCI and CICAMS intend to collaborate on the following activities:

  • Basic and translational research
  • Preclinical research and clinical trials and associated translational research
  • Cancer prevention and early detection trials and epidemiologic studies
  • Joint meetings, conferences, workshops, and informational exchanges

NCI-supported researchers and CICAMS researchers have collaborated on scientific projects for more than 30 years. CICAMS was recently designated China's National Cancer Center and will have an expanded role in China's cancer prevention and control efforts.

NCI Advisory Committee on Clinical Trials Holds First Meeting of 2012

The Clinical Trials and Translational Research Advisory Committee (CTAC) held its first meeting of 2012 on March 7 on the NIH main campus in Bethesda, MD. 

The meeting highlighted NCI-supported early-phase prevention and treatment clinical trials programs, including the Division of Cancer Prevention's Consortia for Early Phase Prevention Trials, and the Early Experimental Therapeutics Program and the Cancer Diagnosis Program's biomarker resources, both in the Division of Cancer Treatment and Diagnosis

The agenda, presentations, and a link to the archived videocast are available online. The next two CTAC meetings are scheduled for July 11 and November 30, 2012.

NCI at American Association of Cancer Research Annual Meeting

NCI at AACR tile

NCI staff will be participating at the American Association for Cancer Research's 103rd Annual Meeting from March 31–April 4 in Chicago, IL. Learn about sessions with NCI staff and activities at the NCI exhibit booth online

Look for highlights from the meeting in the April 3 issue of the NCI Cancer Bulletin.

Dr. John Potter to Deliver First Schatzkin Lecture in Nutritional Epidemiology

Dr. John Potter Dr. John Potter

The inaugural Arthur Schatzkin Distinguished Lecture in Nutritional Epidemiology will be held at 3:00 p.m. on April 16 in Lipsett Amphitheater on the NIH main campus in Bethesda, MD. NCI established this annual lecture to honor the memory of Dr. Arthur Schatzkin, a visionary scientist, mentor, and leader in the field of nutrition and cancer.

Dr. Schatzkin joined NCI in 1984 and served as the chief of the Nutritional Epidemiology Branch from 1995 to 2011. He was committed to understanding the role of nutrition in cancer etiology and prevention and was instrumental in addressing major methodological issues of research in nutritional epidemiology. Dr. Schatzkin passed away in January 2011. 

This year's lecturer is Dr. John Potter, member and senior advisor of the Division of Public Health Sciences at Fred Hutchinson Cancer Research Center and professor of epidemiology at the University of Washington. Dr. Potter's research focuses on the role of diet and physical activity in the development of cancer, with a particular emphasis on the epidemiology, biology, early detection, and prevention of colon cancer. The title of his talk is "Nutrition, Environment, Development, and Cancer: Casting a Wider Net."   

New Complementary and Alternative Medicine Report and Information Posted Online

Cover of NCI Annual Report on Complementary and Alternative Medicine: Fiscal Year 2010

In fiscal year 2010, NCI funded more than 400 projects related to complementary and alternative medicine (CAM), and the American Recovery and Reinvestment Act supported 27 other CAM grants, according to NCI's Annual Report on Complementary and Alternative Medicine.

Projects highlighted in the report include studies on exercise and cancer prevention, curcumin's role in preventing the spread of prostate cancer, and the effect of altering cellular fats on cancer risk. Researchers are also examining whether various foods can prevent or fight cancer. For instance, blackberries are being studied to determine whether they interfere with the growth of tumors in the oral cavity, esophagus, and colon.

In addition, NCI's Physician Data Query (PDQ®) webpage on Prostate Cancer, Nutrition, and Dietary Supplements has been updated with new information on modified citrus pectin, soy, and pomegranates.